The Drug Doesn't Get Approved. The Data Does.
Cyera, Friday, October 16th, 2026
Cyera explains why clinical trial approval depends on an unbroken, trustworthy data trail across many vendors and systems.
Cyera argues that regulators approving a drug are really evaluating the integrity of its data trail.
Modern clinical trials span CROs, trial sites, electronic data capture, lab platforms, genomic pipelines and cloud storage, often a dozen vendors deep, and every handoff risks duplicated records, missing timestamps or values that drift from the original.
The post covers the overlapping regulatory rulebooks life sciences firms face and how data security supports compliance.